1. Home
  2. FATE vs AMTX Comparison

FATE vs AMTX Comparison

Compare FATE & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.48

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.83

Market Cap

134.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
AMTX
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
134.2M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
FATE
AMTX
Price
$2.48
$1.83
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$4.10
$12.00
AVG Volume (30 Days)
1.4M
697.2K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
32.98
EPS
N/A
N/A
Revenue
$6,646,000.00
$77,194,000.00
Revenue This Year
N/A
$49.77
Revenue Next Year
N/A
$57.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
174.60
52 Week Low
$0.93
$1.30
52 Week High
$3.23
$3.80

Technical Indicators

Market Signals
Indicator
FATE
AMTX
Relative Strength Index (RSI) 44.91 53.85
Support Level $2.24 $1.37
Resistance Level $2.88 $2.10
Average True Range (ATR) 0.14 0.12
MACD -0.01 -0.00
Stochastic Oscillator 39.36 47.84

Price Performance

Historical Comparison
FATE
AMTX

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: